» Articles » PMID: 36797232

RGS12 Represses Oral Squamous Cell Carcinoma by Driving M1 Polarization of Tumor-associated Macrophages Via Controlling Ciliary MYCBP2/KIF2A Signaling

Overview
Journal Int J Oral Sci
Date 2023 Feb 16
PMID 36797232
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor-associated macrophages (TAMs) play crucial roles in tumor progression and immune responses. However, mechanisms of driving TAMs to antitumor function remain unknown. Here, transcriptome profiling analysis of human oral cancer tissues indicated that regulator of G protein signaling 12 (RGS12) regulates pathologic processes and immune-related pathways. Mice with RGS12 knockout in macrophages displayed decreased M1 TAMs in oral cancer tissues, and extensive proliferation and invasion of oral cancer cells. RGS12 increased the M1 macrophages with features of increased ciliated cell number and cilia length. Mechanistically, RGS12 associates with and activates MYC binding protein 2 (MYCBP2) to degrade the cilia protein kinesin family member 2A (KIF2A) in TAMs. Our results demonstrate that RGS12 is an essential oral cancer biomarker and regulator for immunosuppressive TAMs activation.

Citing Articles

RGS12 is a target of penehyclidine hydrochloride that enhances oxidative stress and ferroptosis in a model of myocardial ischemia/reperfusion injury by inhibiting the Nrf2 pathway.

Zi C, Wei Y, Zhu Y, Fan J Int J Mol Med. 2025; 55(3).

PMID: 39930821 PMC: 11781519. DOI: 10.3892/ijmm.2025.5493.


Effects of macrophages in OSCC progression.

Dong X, Dong C, Li B Front Immunol. 2025; 15:1517886.

PMID: 39877372 PMC: 11772471. DOI: 10.3389/fimmu.2024.1517886.


Tumor microenvironment in oral squamous cell carcinoma.

Li C, Dong X, Li B Front Immunol. 2025; 15():1485174.

PMID: 39744628 PMC: 11688467. DOI: 10.3389/fimmu.2024.1485174.


N-Methyladenosine Regulates Cilia Elongation in Cancer Cells by Modulating HDAC6 Expression.

Rui Y, Zhang H, Yu K, Qiao S, Gao C, Wang X Adv Sci (Weinh). 2024; 12(2):e2408488.

PMID: 39535388 PMC: 11727115. DOI: 10.1002/advs.202408488.


Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.

Liu L, Liu Q Sci Rep. 2024; 14(1):9914.

PMID: 38688945 PMC: 11061135. DOI: 10.1038/s41598-024-60516-6.

References
1.
Mody M, Rocco J, Yom S, Haddad R, Saba N . Head and neck cancer. Lancet. 2021; 398(10318):2289-2299. DOI: 10.1016/S0140-6736(21)01550-6. View

2.
Mahoney Jr W, Gunaje J, Daum G, Dong X, Majesky M . Regulator of G-protein signaling - 5 (RGS5) is a novel repressor of hedgehog signaling. PLoS One. 2013; 8(4):e61421. PMC: 3630190. DOI: 10.1371/journal.pone.0061421. View

3.
Snow B, Hall R, Krumins A, Brothers G, Bouchard D, Brothers C . GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain. J Biol Chem. 1998; 273(28):17749-55. DOI: 10.1074/jbc.273.28.17749. View

4.
de Palma M, Lewis C . Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell. 2013; 23(3):277-86. DOI: 10.1016/j.ccr.2013.02.013. View

5.
Jayasingam S, Citartan M, Thang T, Mat Zin A, Ang K, Chng E . Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice. Front Oncol. 2020; 9:1512. PMC: 6992653. DOI: 10.3389/fonc.2019.01512. View